Prostate Cancer Japan Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary D. Western Therapeutics Institute, Inc. (DWTI) is a pharmaceutical company. The company discovers and develops new drugs. Its products include K-134, K-115, HMN-214, and HMN-1129. DWTI's K-134 is a clinical candidate for anti-platelet drug which is used for the treatment of arteriosclerosis obliterans. ...

Industries: Therapy | Countries: Japan

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 59 pages

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014', provides an overview of the Chemotherapy Induced Anemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Therapy | Countries: Japan, World

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

  • $ 4 995
  • Industry report
  • by GBI Research
  • August 2014
  • 105 pages

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in ...

Industries: Therapy | Countries: Australia, India, Japan, China, World, United States, Asia, Oceania

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

  • $ 3 013
  • Industry report
  • by Visiongain
  • July 2014
  • 208 pages

Report Details Where is the prostate cancer therapeutics market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 208-page report provides 160 tables, charts, and graphs. Our new study lets you assess leading drugs ...

Industries: Therapy | Countries: United States, World, South Korea, Europe, Brazil, Mexico, Italy, Japan, India, China, United Kingdom, Spain, Russian Federation, France, Germany

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • June 2014
  • 107 pages

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014', provides an overview of the Chemotherapy Induced Neutropenia's therapeutic pipeline. This report provides comprehensive information on the therapeutic ...

Industries: Therapy | Countries: World, Japan, United States

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Global Proton Therapy Outlook 2018

Global Proton Therapy Outlook 2018

  • $ 2 000
  • Industry report
  • by RNCOS
  • June 2014
  • 90 pages

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without affecting the healthy tissues, it is being promulgated as the next big thing in the world of cance ...

Industries: Therapy | Countries: Germany, China, Japan, World

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2014
  • 103 pages

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options Summary GBI Research, the leading business intelligence provider, has released its latest research: "Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 ...

Industries: Therapy | Countries: World, Australia, Japan, China, India

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.